Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Nuchev Pty Ltd ( (AU:NUC) ) has shared an announcement.
Nuchev Limited announced that H&S Group has achieved its second-year performance hurdle under their distribution agreement, leading to the vesting of Tranche 2 performance options. This achievement allows Nuchev to issue up to 8,749,000 shares to H&S Investments, potentially injecting $1.9 million into the company. This capital boost will enhance Nuchev’s financial flexibility, supporting its strategic growth plans. The company appreciates H&S Group’s continued support, which aligns with Nuchev’s objectives for expansion.
The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.
More about Nuchev Pty Ltd
Nuchev is an Australian-based nutritional and wellness business offering products under brands such as Oli6®, Bio Practica, and Medicine Tree. The company distributes globally recognized European brands in Australia and New Zealand through bWellness, focusing on high-quality ingredients and Australian manufacturing standards. Its products are available in major Australian pharmacies, grocery channels, and international markets.
Average Trading Volume: 32,988
Technical Sentiment Signal: Sell
Current Market Cap: A$23.41M
For an in-depth examination of NUC stock, go to TipRanks’ Overview page.